Amedisys, Inc.
AMED
$94.42
-$0.01-0.01%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 14.40M | 19.32M | 25.96M | -80.28M | 25.25M |
| Total Depreciation and Amortization | 14.70M | 14.26M | 14.52M | 14.55M | 14.32M |
| Total Amortization of Deferred Charges | 248.00K | 248.00K | 248.00K | 247.00K | 248.00K |
| Total Other Non-Cash Items | 9.94M | 13.88M | 14.51M | 113.64M | 9.49M |
| Change in Net Operating Assets | -45.83M | 12.60M | -65.08M | 12.60M | -23.34M |
| Cash from Operations | -6.54M | 60.31M | -9.84M | 60.76M | 25.96M |
| Capital Expenditure | -2.67M | -1.89M | -984.00K | -1.39M | -1.35M |
| Sale of Property, Plant, and Equipment | -- | 36.00K | 0.00 | 100.00K | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | -350.00K |
| Divestitures | -- | 0.00 | 0.00 | 0.00 | 47.79M |
| Other Investing Activities | -398.00K | -183.00K | -64.00K | -6.45M | -191.00K |
| Cash from Investing | -3.07M | -2.04M | -1.05M | -7.75M | 45.90M |
| Total Debt Issued | -- | 0.00 | 0.00 | 15.00M | 8.00M |
| Total Debt Repaid | -8.94M | -8.90M | -6.12M | -20.68M | -63.31M |
| Issuance of Common Stock | -- | 0.00 | 873.00K | 1.01M | 816.00K |
| Repurchase of Common Stock | -617.00K | -2.12M | -925.00K | -2.18M | -1.31M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.01M | -2.41M | -82.00K | -4.11M | -1.09M |
| Cash from Financing | -8.55M | -13.43M | -6.25M | -10.95M | -56.89M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.16M | 44.85M | -17.15M | 42.06M | 14.97M |
